SMLR Earnings

SMLR reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 7.49M against an estimate of 7.87M, resulting in a -4.76% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a -10.61% price change on the earnings day and a -16.4% change over the next five days, reflecting market reactions to the results.

Following SMLR's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -10.61% on the day of the release. Over the subsequent five days, it saw a -16.4% change. Historically, SMLR's stock price tends to shift by an average of 2.1% in the 10 days leading up to earnings and 0.12% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SMLR's annual revenue to reach 3.41M, while the EPS is projected at -0.54. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SMLR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SMLR's stock price typically moves by 2.1% in the 10 days before its earnings and 0.12% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.54 and revenue of 3.41M.

The earnings call reveals several concerns: declining revenue and operating losses in the healthcare segment, significant risk from heavy Bitcoin investments, legal expenses from a DOJ settlement, and reliance on equity issuance, which could dilute shareholder value. While there is a positive Bitcoin yield, the volatility and risks associated with Bitcoin, combined with a weak healthcare business performance, outweigh the positives. The Q&A session did not alleviate these concerns, as management's optimism about Bitcoin adoption does not mitigate the financial and operational risks. Overall, these factors suggest a negative stock price reaction.